News | FDA
CorVascularโ€™s VasoGuard Earns FDA 510(k) Clearance

July 29, 2024 โ€” CorVascular, a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) ...

Home July 29, 2024
Home
R-EDByUS score features variables using only prehospital resuscitation data
News | Heart Failure
Rapid and Accurate Prediction Model for Cardiac Arrest Treatment

July 29, 2024 โ€” When it comes to treating cardiac arrest, acting quickly can mean the difference between life and death ...

Home July 29, 2024
Home
Edwards anticipates FDA approval of the JenaValve Trilogy Heart Valve System in late 2025
News | Cardiovascular Business
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

July 29, 2024 โ€” Edwards Lifesciences announced investments that reflect the companyโ€™s deep commitment to advancing ...

Home July 29, 2024
Home
Videos | Virtual and Augmented Reality
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

In this segment of our DAIC Thought Leadership Series, which features one-on-one conversations with cardiovascular ...

Home July 26, 2024
Home
Danish medtech start-up VentriJect has been invited to the upcoming United Nations General Assembly (UNGA) Digital Health Symposium in New York to demonstrate Seismofit, its portable and fast VO2 max estimation solution.
News | Cardiovascular Education
MedTech Startup VentriJect Selected to Demonstrate Siesmofit System to United Nations Digital Health Symposium

July 26, 2024 โ€” VentriJect, a Danish medtech start-up seeking to revolutionize the way cardiorespiratory fitness (CRF) ...

Home July 26, 2024
Home
BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for patients with ischemic heart failure of reduced ejection fraction (HFrEF) has commenced enrollment in the United States
News | Cardiovascular Clinical Studies
Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

July 25, 2024 โ€” BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
In a study conducted by Brigham & Womenโ€™s Hospital, Nanox.AI-Based Analysis helps Reveal Coronary Artery Calcium in over 50% of IMID Patients; Lead author Brittany Weber, MD, PhD, declared as โ€˜Young Investigator Awardsโ€™ Winner
News | Artificial Intelligence
Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024

July 25, 2024 โ€” Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution ...

Home July 25, 2024
Home
NeuSight PET-CT 3D 64 slice scanner
News | PET-CT
Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT

July 25, 2024 โ€” Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Home July 25, 2024
Home
Videos | HIMSS
VIDEO: One on One with Hal Wolf, FHIMSS, HIMSS President and CEO

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Home July 24, 2024
Home
Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary research presented by study author Qiuyu (Violet) Sun, B.Sc., a Ph.D. candidate at the University of Alberta in Canada, during an American Heart Association meeting in Chicago this week.
News | AHA
Increasing Cardiac Ketones May Help Heart Failure, per Mouse Study Presented at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024

July 24, 2024 โ€” Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF ...

Home July 24, 2024
Home
FibriCheck is now the only FDA-cleared smartphone application for heart rhythm monitoring with ECG equivalence in the U.S.
News | ECG Monitoring Services
FibriCheck Enters US Market with FDA Clearance

July 24, 2024 โ€” After a rigorous investigation procedure by the Food and Drug Administration, FibriCheck is now FDA ...

Home July 24, 2024
Home
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies.
News | Atrial Fibrillation
Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

July 24, 2024 โ€” Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home July 24, 2024
Home
SCCT24
News | SCCT
SCCT Awards Best Original Science of 19th Annual Scientific Meeting

July 23, 2024 โ€” The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award ...

Home July 23, 2024
Home
News | Cardiovascular Education
International Atherosclerosis Society Issues New White Paper Underscoring Inflammation's Role, Offering Key Recommendations

July 23, 2024 โ€” The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper ...

Home July 23, 2024
Home
EMVision's First Responder device aims to fundamentally transform stroke and traumatic brain injury outcomes for all patients
News | Cardiac Imaging
Australian Medtech EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

July 23, 2024 โ€” EMVision, an Australian medical device company focused on the development and commercialization of ...

Home July 23, 2024
Home
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now